Everyone should always do their own due diligence on a thing. You can listen and consider what I have to say, but ultimately you make your own decisions based on your system. My system of due diligence points to VDRM as a winner, but that's just me...
Viaderma's technologies and methods have numerous applications in pharmaceuticals, neutraceuticals, cosmetics, cannabis extract formulations, and many other things, and so forthcoming deals with any number of companies in these industries to make more effective and affordable medicines and products to meet the needs of consumers is the ultimate goal of Viaderma. The business model is to license this advanced transdermal technology, which by all accounts is efficacious, effective and sound. And that is why it's actively being implemented in a number of formulations that have great potential for future consumer products, over the counter treatments and pharmaceutical medications. It is believed that these efforts and subsequent licensing deals will result in substantial licensing revenues. The projections all point to a tremendous growth phase for this company.
News 
Market Data 
Discover 
AI
